These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16871252)

  • 1. Myostatin and insulin-like growth factors in uremic sarcopenia: the yin and yang in muscle mass regulation.
    Mak RH; Rotwein P
    Kidney Int; 2006 Aug; 70(3):410-2. PubMed ID: 16871252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Work-induced changes in skeletal muscle IGF-1 and myostatin gene expression in uremia.
    Sun DF; Chen Y; Rabkin R
    Kidney Int; 2006 Aug; 70(3):453-9. PubMed ID: 16871256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of melanocortin signaling ameliorates uremic cachexia.
    Cheung WW; Rosengren S; Boyle DL; Mak RH
    Kidney Int; 2008 Jul; 74(2):180-6. PubMed ID: 18432186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myostatin, insulin-like growth factor-1, and leukemia inhibitory factor mRNAs are upregulated in chronic human disuse muscle atrophy.
    Reardon KA; Davis J; Kapsa RM; Choong P; Byrne E
    Muscle Nerve; 2001 Jul; 24(7):893-9. PubMed ID: 11410916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myostatin gene deletion prevents glucocorticoid-induced muscle atrophy.
    Gilson H; Schakman O; Combaret L; Lause P; Grobet L; Attaix D; Ketelslegers JM; Thissen JP
    Endocrinology; 2007 Jan; 148(1):452-60. PubMed ID: 17038559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skeletal muscle mRNA for IGF-IEa, IGF-II, and IGF-I receptor is decreased in sedentary chronic hemodialysis patients.
    Wang H; Casaburi R; Taylor WE; Aboellail H; Storer TW; Kopple JD
    Kidney Int; 2005 Jul; 68(1):352-61. PubMed ID: 15954927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum concentrations of insulin-like growth factor-1, members of the TGF-beta superfamily and follistatin do not reflect different stages of dynapenia and sarcopenia in elderly women.
    Hofmann M; Halper B; Oesen S; Franzke B; Stuparits P; Tschan H; Bachl N; Strasser EM; Quittan M; Ploder M; Wagner KH; Wessner B
    Exp Gerontol; 2015 Apr; 64():35-45. PubMed ID: 25681638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged absence of myostatin reduces sarcopenia.
    Siriett V; Platt L; Salerno MS; Ling N; Kambadur R; Sharma M
    J Cell Physiol; 2006 Dec; 209(3):866-73. PubMed ID: 16972257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of exercise on mRNA levels for growth factors in skeletal muscle of hemodialysis patients.
    Kopple JD; Cohen AH; Wang H; Qing D; Tang Z; Fournier M; Lewis M; Casaburi R; Storer T
    J Ren Nutr; 2006 Oct; 16(4):312-24. PubMed ID: 17046615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of insulin, insulin-like growth factors, and muscle regulatory factors in the compensatory growth of the trout (Oncorhynchus mykiss).
    Montserrat N; Gabillard JC; Capilla E; Navarro MI; Gutiérrez J
    Gen Comp Endocrinol; 2007 Feb; 150(3):462-72. PubMed ID: 17196198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myostatin is a procachectic growth factor during postnatal myogenesis.
    McFarlane C; Sharma M; Kambadur R
    Curr Opin Clin Nutr Metab Care; 2008 Jul; 11(4):422-7. PubMed ID: 18542002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms involving IGF-1 and myostatin to induce muscle hypertrophy as a therapeutic strategy for Duchenne muscular dystrophy.
    Patel K; Macharia R; Amthor H
    Acta Myol; 2005 Dec; 24(3):230-41. PubMed ID: 16629058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of muscle mass by myostatin.
    Lee SJ
    Annu Rev Cell Dev Biol; 2004; 20():61-86. PubMed ID: 15473835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myostatin and its precursor protein are increased in the skeletal muscle of patients with Type-II muscle fibre atrophy.
    Wójcik S; Nogalska A; Engel WK; Askanas V
    Folia Morphol (Warsz); 2008 Feb; 67(1):6-12. PubMed ID: 18335407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The growth factor myostatin, a key regulator in skeletal muscle growth and homeostasis.
    Matsakas A; Diel P
    Int J Sports Med; 2005 Mar; 26(2):83-9. PubMed ID: 15726494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy with anabolic growth factors to prevent muscle atrophy.
    Schakman O; Thissen JP
    Curr Opin Clin Nutr Metab Care; 2006 May; 9(3):207-13. PubMed ID: 16607118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Inhibitory Core of the Myostatin Prodomain: Its Interaction with Both Type I and II Membrane Receptors, and Potential to Treat Muscle Atrophy.
    Ohsawa Y; Takayama K; Nishimatsu S; Okada T; Fujino M; Fukai Y; Murakami T; Hagiwara H; Itoh F; Tsuchida K; Hayashi Y; Sunada Y
    PLoS One; 2015; 10(7):e0133713. PubMed ID: 26226340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis and myostatin mRNA are upregulated in the skeletal muscle of patients with chronic kidney disease.
    Verzola D; Procopio V; Sofia A; Villaggio B; Tarroni A; Bonanni A; Mannucci I; De Cian F; Gianetta E; Saffioti S; Garibotto G
    Kidney Int; 2011 Apr; 79(7):773-82. PubMed ID: 21228768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postnatal expression of myostatin propeptide cDNA maintained high muscle growth and normal adipose tissue mass in transgenic mice fed a high-fat diet.
    Yang J; Zhao B
    Mol Reprod Dev; 2006 Apr; 73(4):462-9. PubMed ID: 16437538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myostatin and MyoD family expression in skeletal muscle of IGF-1 knockout mice.
    Miyake M; Hayashi S; Sato T; Taketa Y; Watanabe K; Hayashi S; Tanaka S; Ohwada S; Aso H; Yamaguchi T
    Cell Biol Int; 2007 Oct; 31(10):1274-9. PubMed ID: 17590360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.